BLACK DIAMOND THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $963.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $42.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $921.00K, a 35.84% increase year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $251.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$475.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $349.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$33.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$2.27M.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.02M, a 162.53% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $963.00K 10-Q · filed 2026-08-05 | $1.21M derived: sum of 3 quarters · filed 2026-08-05 | $739.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $921.00K 10-Q · filed 2026-05-07 | $1.17M derived: sum of 2 quarters · filed 2026-05-07 | $697.00K derived: sum of 3 quarters · filed 2026-05-07 | $592.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$224.00K derived: sum of 2 quarters · filed 2026-03-16 | -$329.00K derived: sum of 3 quarters · filed 2026-08-05 | $349.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$580.00K derived: sum of 2 quarters · filed 2026-08-05 | $98.00K 10-Q · filed 2025-11-06 | -$157.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $573.00K 10-Q · filed 2026-08-05 | $318.00K derived: sum of 3 quarters · filed 2026-08-05 | -$609.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $678.00K 10-Q · filed 2026-05-07 | $423.00K derived: sum of 2 quarters · filed 2026-05-07 | -$504.00K derived: sum of 3 quarters · filed 2026-05-07 | -$328.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$1.18M derived: sum of 2 quarters · filed 2026-03-16 | -$1.01M derived: sum of 3 quarters · filed 2026-03-16 | -$33.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$927.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$751.00K derived: sum of 2 quarters · filed 2025-11-06 | $222.00K 10-Q · filed 2025-11-06 | $63.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.15M 10-Q · filed 2025-08-07 | $990.00K derived: sum of 3 quarters · filed 2025-08-07 | $318.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $973.00K 10-Q · filed 2025-05-12 | $814.00K derived: sum of 2 quarters · filed 2025-05-12 | $142.00K derived: sum of 3 quarters · filed 2025-05-12 | -$909.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$831.00K derived: sum of 2 quarters · filed 2025-03-06 | -$1.88M derived: sum of 3 quarters · filed 2025-03-06 | -$2.27M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$672.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$1.72M derived: sum of 2 quarters · filed 2024-11-05 | -$2.11M 10-Q · filed 2024-11-05 | -$4.00M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.43M 10-Q · filed 2024-08-06 | -$3.33M derived: sum of 3 quarters · filed 2024-08-06 | -$4.20M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$383.00K 10-Q · filed 2024-05-09 | -$2.28M derived: sum of 2 quarters · filed 2024-05-09 | -$3.15M derived: sum of 3 quarters · filed 2024-05-09 | -$4.05M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$2.77M derived: sum of 2 quarters · filed 2024-03-12 | -$3.67M derived: sum of 3 quarters · filed 2024-03-12 | -$1.02M 10-K · filed 2024-03-12 |
| 2022-09-30 | -$871.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.77M derived: sum of 2 quarters · filed 2023-11-06 | $880.00K 10-Q · filed 2023-11-06 | $345.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | -$897.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.75M 10-Q · filed 2023-08-11 | $1.22M derived: sum of 3 quarters · filed 2023-08-11 | $423.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $2.65M 10-Q · filed 2023-05-09 | $2.11M derived: sum of 2 quarters · filed 2023-05-09 | $1.32M derived: sum of 3 quarters · filed 2023-05-09 | $1.47M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$1.33M derived: sum of 2 quarters · filed 2023-03-09 | -$1.18M derived: sum of 3 quarters · filed 2023-03-09 | $1.63M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$793.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$642.00K derived: sum of 2 quarters · filed 2022-11-08 | $2.16M 10-Q · filed 2022-11-08 | $3.29M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.96M 10-Q · filed 2022-08-09 | $4.09M derived: sum of 3 quarters · filed 2022-08-09 | $3.69M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $2.81M 10-Q · filed 2022-05-11 | $3.94M derived: sum of 2 quarters · filed 2022-05-11 | $3.54M derived: sum of 3 quarters · filed 2022-05-11 | $2.40M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $731.00K derived: sum of 2 quarters · filed 2022-03-17 | -$409.00K derived: sum of 3 quarters · filed 2022-03-17 | $3.44M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$1.54M derived: sum of 2 quarters · filed 2021-11-08 | $2.31M 10-Q · filed 2021-11-08 | $3.06M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.71M 10-Q · filed 2021-08-12 | $3.46M derived: sum of 3 quarters · filed 2021-08-12 | $3.43M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $3.85M 10-Q · filed 2021-05-07 | $4.60M derived: sum of 2 quarters · filed 2021-05-07 | $4.57M derived: sum of 3 quarters · filed 2021-05-07 | $3.68M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $722.00K derived: sum of 2 quarters · filed 2021-03-25 | -$171.00K derived: sum of 3 quarters · filed 2021-03-25 | $1.02M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$925.00K derived: sum of 2 quarters · filed 2020-11-10 | $270.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$893.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $302.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $1.20M 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | -$12.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |